| Serial Number | 90860167 |
| Word Mark | LEALING BIOPHARMA |
| Filing Date | Monday, August 2, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 23, 2022 |
| Registration Number | 6825724 |
| Registration Date | Tuesday, August 23, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 7, 2022 |
| Goods and Services | Immunostimulants; Biological preparations for the treatment of cancer; Biological preparations for the treatment of infectious diseases; Disinfecting wipes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents |
| Transliteration Statement | The word ¿LEALING¿ has no meaning in a foreign language. |
| Disclaimer with Predetermined Text | "BIOPHARMA" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 28, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Saturday, July 31, 2021 |
| First Use In Commerce Date | Saturday, July 31, 2021 |
| Party Name | Liling biopharmaceuticals (Suzhou) Co.,Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Jiangsu 215000 CN |
| Party Name | Liling biopharmaceuticals (Suzhou) Co.,Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Jiangsu 215000 CN |
| Party Name | Liling biopharmaceuticals (Suzhou) Co.,Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Jiangsu 215000 CN |
| Event Date | Event Description |
| Tuesday, August 23, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 23, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 7, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 7, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 18, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, May 5, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 3, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, May 3, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 3, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 3, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, April 29, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, September 28, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, August 5, 2021 | NEW APPLICATION ENTERED IN TRAM |